Belén Garijo is Vice Chair of the Executive Board and Deputy CEO of Merck KGaA, Darmstadt, Germany, as well as CEO of Healthcare. She joined Merck KGaA, Darmstadt, Germany, in 2011 as Chief Operating Officer of the Biopharma business, becoming President and CEO of Healthcare in 2015. In July 2020, Belén Garijo was appointed Vice Chair of the Executive Board and Deputy CEO in addition to her role as CEO of the Healthcare business.
Under her leadership, Healthcare at Merck KGaA, Darmstadt, Germany, has become a key player in the area of oncology, immunology and immuno-oncology, after the profound repositioning of the portfolio, the reorganization of R&D and the transformation of the commercial model. Belén Garijo has forged two major global alliances to further contribute to the portfolio’s maximization. She has also focused on globalization by expanding the business to growth markets as well as to Japan and the U.S.
Before joining Merck KGaA, Darmstadt, Germany, Belén Garijo served as the Senior Vice President of Global Operations Europe at Sanofi-Aventis and Global Integration Leader of Genzyme after its acquisition by Sanofi. She previously held several local and global executive positions, both in R&D and commercial, at various companies at the forefront of the Healthcare sector.
She started her career as a practicing physician at La Paz hospital in Madrid before moving to the pharmaceutical industry.
Belén Garijo was born on July 31, 1960 in Almansa, Spain. She is a medical doctor, specialized in clinical pharmacology. She is married and has two daughters.
Responsibility for Group functions
- Group Human Resources
- Environment, Health, Safety, Security, Quality (EQ)
- L’Oréal SA, Independent Director of the Board
- PhRMA (Pharmaceutical Research and Manufacturers of America), Member of the Board
- Banco Bilbao Vizcaya Argentaria S.A., Independent Director of the Board